Press Release: Medicines for children: more research, more availability and more information compared with 5 years ago

The Commission published a progress report on medicines for children covering the five years since the Paediatric Regulation came into force. This preliminary snapshot points to improvements in the paediatric medicines landscape: better and safer research, more medicines for children on the EU market and more information for parents and health professionals.

Although it takes at least another five years for the full impact of the legislation to be understood, due to the long development cycles for medicines, the EU commitment to better medicines for children is clear.

• Primary Source

ESO: Background Information: 5-year Report to the European Commission: General report on the experience acquired as a result of the application of the Paediatric Regulation http://www.europeansources.info/record/5-year-report-to-the-european-commission-general-report-on-the-experience-acquired-as-a-result-of-the-application-of-the-paediatric-regulation/

ESO: Key source: Paediatric medicines [European Medicines Agency, 2017] http://www.europeansources.info/record/website-paediatric-medicines/

EMA: News, 24.06.13: European Commission report highlights successes of the first five years of the EU Paediatric Regulation http://www.emea.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/06/news_detail_001823.jsp&mid=WC0b01ac058004d5c1

---